ABSTRACT -In order to obtain basic risk assessment data on human health exposure to volatile organic compound (VOC) vapor by inhalation, a whole-body inhalation exposure system which allows blood collection during the exposure period was designed. The system was tested using chloroform as a model VOC. Chloroform vapor, sampled from the supply-header, animal-chambers and exhaust-headthe vapor through the system was also constant. Rats were exposed to chloroform vapor and blood collected from the tail during exposure to the chloroform vapor. The chloroform concentration in the blood increased during the initial 60 min of exposure, and afterwards its concentration remained at about 2 μg/ ml from 60 to 360 min. In conclusion, our design allows blood to be collected from individual rats during exposure by inhalation to test VOCs and changes in the blood concentration of the VOC during exposure to be assessed.
INTRODUCTION
Inhalation exposure studies on animals using volatile organic compounds (VOCs) have delineated doseresponse relationships to determine effective endpoints for the risk assessment of people exposed to VOC vapor by inhalation. The vapor concentrations in most of these studies is used as the endpoint dose when determining the dose-response effects. However, it is the internal dose, i.e., the concentration of the VOC in the blood, and factors such as time-course changes in the blood concentration of the VOC which is usually more directly related to many of the adverse health effects of a particular VOC.
Blood collection from animals during the inhalation exposure period has been reported, but only when using a nose-only inhalation exposure system (CERI News, 2005) . Blood concentrations of inhaled chemicals using whole-body inhalation systems have been described in some reports Wang et al., 1995; Hori et al., 1999) , but the blood concentration data was obtained only after termination of inhalation exposure period. For whole-body inhalation exposure studies, the animals are individually housed in an inhalation exposure chamber and are exposed to the chemical substance; under these whole-body exposure conditions, it is impossible to collect the blood from the animal during the inhablood concentration data that accurately corresponds to the exposure concentration.
We have designed a whole-body inhalation exposure system that allows blood to be collected from the tails of exposed rats during the inhalation exposure period. The system was verified using chloroform as a model VOC: chloroform is found in both outdoor and indoor air (International Programme on Chemical Safety, 1994; International Agency for Research on Cancer, 1999), and is a carcinogen (Yamamoto et al., 2002; Nagano et al., 2006) .
MATERIALS AND METHODS

Whole-body inhalation exposure system
The system is composed of two parts: a whole-body inhalation apparatus in which the rats are exposed to chemical vapors and a blood-collection module in which the rats are housed during exposure and allows blood to be collected from the tail.
The whole-body inhalation apparatus is shown in Design and performance of a system for blood collection of rats under whole-body inhalation exposure Makoto Take, Makoto Ohnishi, Kasuke Nagano, Seigo Yamamoto and Shoji Fukushima Fig. 1 . A chemical vapor-air mixture is generated by bubbling clean air through the test VOC. The vapor is supplied to the animal chambers via the supply-header and vented via the exhaust-header. A flow-meter and flowcontrol-valve are attached to each animal-chamber to control the flow rate of the chemical vapor-air mixture through the animal-chamber. The blood-collection module is inserted into the animal-chamber and is held in place by a holder-nut. The inhalation apparatus has 9 vapor sampling ports: one at each end of the supply-header (S-1 and S-2), one in each animal-chamber (A-1-6), and one in the exhaust-header (E-1). The supply-header and animal-chamber are made of acrylic acid resin, and the holder-nut and exhaust-header are made of poly vinyl chloride resin. The blood-collection module is shown in Fig. 2 . This module is composed of an animal-housing assembly and a tail-holder assembly. The animal-housing assembly consists of an animal-holder made of acrylic acid resin equipped with a dome type head-cover. The animalafter it is placed within the whole-body inhalation apparatus. The tail-holder assembly is composed of a siliconseptum made of silicon rubber and a backup-plate made of stainless steel. The silicon-septum forms an airtight gasket between the backup-plate and the animal-holder to prevent chemical vapor leakage. A hole in the silicon-septum (position X in Figs. 2 and 3) allows for protrusion of the tail for blood collection and is smaller than the tail root of the rat to prevent vapor leakage. The animal-housthe holder-nut which also holds the blood-collection module in place in the whole-body inhalation apparatus.
The test animal is housed and blood collected as follows. The rat is placed in the animal-holder and the headhead-cover is fixed in place with the head-cover screw and the animal-housing assembly is placed into the wholebody inhalation apparatus. Finally, the rat's tail is passed through the hole of the tail-holder assembly, and the tailholder, the animal-housing assembly and the whole-body holder-nut. The rat is exposed to vapor and blood is collected from the tail vein as shown in Fig. 3 .
Temperature relative humidity of the system is measured by thermo-hygro meter at 6 min intervals, and maintained in a range of 22 ± 3°C and 51 ± 8%, respectively.
-250 to 260 ml/min. 
Chemicals
Chloroform (purity greater than 99.0%) was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). For the present study, chloroform vapor at a concentration of 100 ppm (v/v) was generated by bubbling clean air through liquid chloroform.
Animals
Male Crl:CD (SD) rats (SPF) 9 weeks of age were purchased from Charles River Japan, Inc. (Kanagawa, Japan). Their body weights ranged from 341 to 368 g. Experiments were initiated after a one-week acclimation period. The animals were cared for according to the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) , and the present study was approved by the ethics committee of the Japan Bioassay Research Center (JBRC).
Study design
The performance of the whole-body inhalation expo-1. A performance study of the system without rats (study 1). The performance of the system without rats was rats (study 2). System performance with rats was ana-6 rats over the course of a single exposure day. In addition, leakage of chloroform vapor from the tail-holder assembly of each animal-chamber was examined.
form in the blood of test animals during the exposure to chloroform vapor (study 3). Six rats was were exposed to chloroform vapor (100 ppm) for 6 hr, and blood collected at 1, 30, 60, 120, 180, 240, 300 and 360 min from the start of exposure.
Analysis of chloroform vapor concentration in supply-header, animal-chamber and exhaust-header
Air in the supply-header, animal-chambers and exhaustheader was sampled using a RT731 (GL Sciences, Tokyo, Japan) every 15 min. Air at the rat tail outlet was sampled by a gas-tight syringe every 15 min. Chloroform vapor concentration was assessed by gas chromatography (GC) using Agilent Technologies 6890 (Agilent Technologies, Santa Clara, CA, USA) gas chromatography system (column, J&W DB-1 0.53 mm × 5 m; oven temperature, 40°C; injection and detection temperature, 200°C; detector, FID; carrier gas, helium at 7.5 ml/min).
Rats blood sampling and treatment
Blood was collected from the tail vein of each rat during the inhalation exposure period at 1, 30, 60, 120, 180, 240, 300 and 360 min from the start of exposure. 0.1 ml blood samples were collected into 10-ml headspace sampler (HS)-vials and 0.1 ml of distilled water was added to each sample and the vials sealed immediately with an aluminum crimp cup.
Analysis of blood concentration
spectrometry (MS) using Agilent Technologies 7694 (Agilent Technologies) headspace sampler (oven temperature, 80°C; loop temperature, 130°C; vial equilibration time, 10 min) and Agilent Technologies 5973N (Agilent Technologies) gas chromatography-mass spectrometry system (column, J&W DB-1 0.25 mm × 60 m; oven temperature, 80°C; ion source temperature, 230°C; carri--
RESULTS AND DISCUSSION
In the present study, a whole-body inhalation exposure system was designed to enable blood collection from rats during the period of exposure to a VOC; chloroform was used as a model VOC.
A performance study of the system without rats (study 1) Table 1 (study 1) shows the chloroform vapor concentration at the sampling ports of the supply-header, animalchamber and exhaust-header. The average concentrations in the supply-header, animal-chamber and exhaust-header over the course of a 6 hr exposure period were in the animal-chamber during this period was maintained within a range of 250 to 260 ml/min. Thus, the supply-header was able to supply uniform stable chloroform vapor to each animal-chamber, demonstrating good performance of the system.
(study 2)
Table 1 (study 2) shows the chloroform vapor concentration at the sampling ports of the supply-header, animalchamber and exhaust-header. The average concentrations in the supply-header, animal-chamber and exhaust-head-er over the course of a 6 hr exposure period were in the range of 100.1 to 101.3 ppm with C.V. being less than -ing this period was maintained within a range of 250 to 260 ml/min. Thus, the supply-header was able to supply uniform stable chloroform vapor to each animal-chamber when the chambers contained test animals. In addition, there was no detectable chloroform vapor at the rat tail outlet of the animal-chambers, indicating that the backupplate and silicon-septum formed an effective seal against the tail root of the rat. Overall, the performance of the system was rated as excellent.
Use the system to analyze the concentration chloroform in the blood of test animals during the exposure to chloroform vapor (study 3) Rats were exposed to chloroform vapor for 6 hr, and blood was collected from each animal during the course of the exposure period. The chloroform vapor concentration (mean ± S.D.) at the sampling ports of the supply-header (S-1 and S-2 in Fig. 1 ) and exhaust-header (E-1 in Fig.1 ) was 100.8 ± 0.82, 101.6 ± 0.81 and 100.8 ± 0.94 ppm, respectively, with C.V. of 0.82 (S-1 in Fig. 1 ), rate through each animal-chamber was maintained within a range of 250 to 260 ml/min.
During the inhalation exposure period, blood samples were collected 8 times from each rat. Table 2 shows the by HS-GC/MS. Chloroform was detected in the blood of all rats at 1 min after the start of exposure demonstrating that chloroform was quickly absorbed into the blood stream. The chloroform concentration in blood of all rats showed an increase from 1 to 60 min, and afterwards, its concentration remained in the range from 1.89 to 2.04 g/ ml, with C.V. in the range of 5.02 to 12.96%. The chloroform concentrations in the blood of the different rats was found to very similar. Time-course changes in blood chloroform concentration were also very similar among the different animals.
Finally, six rats were exposed by inhalation to 100 ppm (v/v) of chloroform vapor for 6 hr/day and 5 days/week using the whole-body inhalation exposure system. No marked body weight depression occurred nor were abnormal clinical signs observed in the rats during or after the inhalation exposure period. The system performed within the parameters observed during the single-day exposure period.
In conclusion, blood collection from individual animals was possible during whole-body inhalation exposure to a model VOC. The system should be effective for examining the time-course changes in blood concentra- c) The chloroform vapor concentration at each sampling port is expressed as the mean ± S.D. of concentrations measured at every 15 min over the course of a 6 hr exposure period. tions of other VOCs during exposure. This information can be used as basic data for risk assessment of human health exposure to VOC vapor by inhalation.
